{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:29:25Z","timestamp":1791404965857,"version":"4.3.3"},"reference-count":49,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3,1]]},"DOI":"10.1210\/jc.2013-3921","type":"journal-article","created":{"date-parts":[[2014,1,14]],"date-time":"2014-01-14T05:06:36Z","timestamp":1389675996000},"page":"852-860","source":"Crossref","is-referenced-by-count":94,"title":["Effects of Recombinant Human Growth Hormone Therapy on Bone Mineral Density in Adults With Growth Hormone Deficiency: A Meta-Analysis"],"prefix":"10.1210","volume":"99","author":[{"given":"Maya","family":"Barake","sequence":"first","affiliation":[{"name":"Neuroendocrine Unit (M.B., A.K., N.A.T.), Boston, Massachusetts 2114"},{"name":"Department of Medicine, Massachusetts General Hospital, and Harvard Medical School (M.B., A.K., N.A.T.), Boston, Massachusetts 2114"},{"name":"Bellevue University Medical Center (M.B.), 00961 Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Klibanski","sequence":"additional","affiliation":[{"name":"Neuroendocrine Unit (M.B., A.K., N.A.T.), Boston, Massachusetts 2114"},{"name":"Department of Medicine, Massachusetts General Hospital, and Harvard Medical School (M.B., A.K., N.A.T.), Boston, Massachusetts 2114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Tritos","sequence":"additional","affiliation":[{"name":"Neuroendocrine Unit (M.B., A.K., N.A.T.), Boston, Massachusetts 2114"},{"name":"Department of Medicine, Massachusetts General Hospital, and Harvard Medical School (M.B., A.K., N.A.T.), Boston, Massachusetts 2114"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113362496500_B1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/223403a0","article-title":"Effect of growth hormone on skeletal mass in adult dogs","volume":"223","author":"Harris","year":"1969","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019041113362496500_B2","first-page":"327","article-title":"Acquisition of bone mass in normal individuals and in patients with growth hormone deficiency","volume":"16","author":"Baroncelli","year":"2003","journal-title":"J Pediatr Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113362496500_B3","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1210\/jcem.83.2.4594","article-title":"Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee","volume":"83","author":"Carroll","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113362496500_B4","first-page":"669","article-title":"Reduced bone mineral density in patients with adult onset growth hormone deficiency","volume":"78","author":"Holmes","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113362496500_B5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1530\/eje.0.1370240","article-title":"Increased fracture frequency in adult patients with hypopituitarism and GH deficiency","volume":"137","author":"Rosen","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113362496500_B6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.0300-0664.2001.01464.x","article-title":"Fracture risk is increased in patients with GH deficiency or untreated prolactinomas\u2014a case-control study","volume":"56","author":"Vestergaard","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113362496500_B7","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1359\/jbmr.2001.16.2.398","article-title":"The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density","volume":"16","author":"Wuster","year":"2001","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113362496500_B8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4158\/EP.9.1.64","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children\u20142003 update","volume":"9","author":"Gharib","year":"2003","journal-title":"Endocr Pract"},{"key":"key\n\t\t\t\t2019041113362496500_B9","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/EJE-07-0631","article-title":"Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia","volume":"157","author":"Ho","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113362496500_B10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1530\/EJE-11-1072","article-title":"Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency","volume":"166","author":"Elbornsson","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113362496500_B11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1530\/EJE-11-0558","article-title":"Body composition and quality of life in adults treated with GH therapy: a systematic review and meta-analysis","volume":"166","author":"Hazem","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113362496500_B12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2265.2004.01935.x","article-title":"Growth hormone replacement in adults and bone mineral density: a systematic review and meta-analysis","volume":"60","author":"Davidson","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113362496500_B13","first-page":"257","article-title":"Growth hormone deficiency and replacement in patients with treated Cushing's disease, prolactinomas and non-functioning pituitary adenomas: effects on body composition, glucose metabolism, lipid status and bone mineral density","volume":"66","author":"Colson","year":"2006","journal-title":"Horm Res"},{"key":"key\n\t\t\t\t2019041113362496500_B14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1365-2265.2004.02018.x","article-title":"Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease","volume":"60","author":"Johannsson","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113362496500_B15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF03343570","article-title":"Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients","volume":"22","author":"Longobardi","year":"1999","journal-title":"J Endocrinol Invest"},{"key":"key\n\t\t\t\t2019041113362496500_B16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00223-010-9459-8","article-title":"Predictors of bone responsiveness to growth hormone (GH) replacement in adult GH-deficient patients","volume":"88","author":"Rossini","year":"2011","journal-title":"Calcif Tissue Int"},{"key":"key\n\t\t\t\t2019041113362496500_B17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"key\n\t\t\t\t2019041113362496500_B18","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t2019041113362496500_B19","first-page":"507","article-title":"Prolonged treatment with recombined growth hormone improves bone measures: study of body composition in 21 deficient adults on treatment","volume":"62","author":"Beckers","year":"2001","journal-title":"Ann Endocrinol (Paris)"},{"key":"key\n\t\t\t\t2019041113362496500_B20","first-page":"970","article-title":"Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency","volume":"85","author":"Biller","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113362496500_B21","first-page":"107","article-title":"The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults","volume":"83","author":"Cuneo","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113362496500_B22","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1530\/eje.0.1360282","article-title":"Effects of growth hormone (GH) replacement on bone metabolism and mineral density in adult onset of GH deficiency: results of a double-blind placebo-controlled study with open follow-up","volume":"136","author":"Finkenstedt","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113362496500_B23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-2007-978591","article-title":"Effects of long-term treatment with GH in the bone mineral density of adults with hypopituitarism and GH deficiency and after discontinuation of GH replacement","volume":"32","author":"Gomez","year":"2000","journal-title":"Horm Metab Res"},{"key":"key\n\t\t\t\t2019041113362496500_B24","first-page":"2143","article-title":"Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency","volume":"83","author":"Janssen","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113362496500_B25","first-page":"2002","article-title":"Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency","volume":"84","author":"Johansson","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113362496500_B26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s002239900392","article-title":"Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency","volume":"62","author":"Kotzmann","year":"1998","journal-title":"Calcif Tissue Int"},{"key":"key\n\t\t\t\t2019041113362496500_B27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0011-393X(00)88519-7","article-title":"Effect of growth hormone replacement therapy on bone mass, bone metabolism, and body composition in adult patients with growth homone deficiency","volume":"60","author":"Luisetto","year":"1999","journal-title":"Current Therapeutic Res"},{"key":"key\n\t\t\t\t2019041113362496500_B28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-2265.1998.00405.x","article-title":"Serum collagen crosslinks as markers of bone turn-over during GH replacement therapy in growth hormone deficient adults","volume":"48","author":"Rodriguez-Arnao","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113362496500_B29","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/BF03349011","article-title":"Effects of recombinant growth hormone (GH) treatment on bone mineral density and body composition in adults with childhood onset growth hormone deficiency","volume":"19","author":"Sartorio","year":"1996","journal-title":"J Endocrinol Invest"},{"key":"key\n\t\t\t\t2019041113362496500_B30","first-page":"41","article-title":"Preliminary study of the effects of growth hormone substitution therapy on bone mineral density and serum osteocalcin levels in adults with growth hormone deficiency","volume":"128","author":"Thoren","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"key":"key\n\t\t\t\t2019041113362496500_B31","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1365-2265.2005.02343.x","article-title":"Effects of 10 years of growth hormone (GH) replacement therapy in adult GH-deficient men","volume":"63","author":"Arwert","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113362496500_B32","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1359\/jbmr.2002.17.6.1081","article-title":"The effects of growth hormone replacement therapy on bone metabolism in adult-onset growth hormone deficiency: a 2-year open randomized controlled multicenter trial","volume":"17","author":"Bex","year":"2002","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113362496500_B33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/eje.1.01817","article-title":"One year of GH replacement therapy with a fixed low-dose regimen improves body composition, bone mineral density and lipid profile of GH-deficient adults","volume":"152","author":"Boguszewski","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113362496500_B34","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1359\/JBMR.050613","article-title":"Effect of long-term growth hormone treatment on bone mass and bone metabolism in growth hormone-deficient men","volume":"20","author":"Bravenboer","year":"2005","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113362496500_B35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2265.2001.01284.x","article-title":"Effects of 6 years of growth hormone (GH) treatment on bone mineral density in GH-deficient adults","volume":"55","author":"Clanget","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113362496500_B36","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2265.2001.01246.x","article-title":"The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study","volume":"54","author":"Drake","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113362496500_B37","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1210\/jcem.86.10.7887","article-title":"A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices","volume":"86","author":"Gotherstrom","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113362496500_B38","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/BF03345574","article-title":"Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender","volume":"31","author":"Rota","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"key\n\t\t\t\t2019041113362496500_B39","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/BF03343851","article-title":"Effects of 12-month GH treatment on bone metabolism and bone mineral density in adults with adult-onset GH deficiency","volume":"24","author":"Sartorio","year":"2001","journal-title":"J Endocrinol Invest"},{"key":"key\n\t\t\t\t2019041113362496500_B40","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1359\/jbmr.070205","article-title":"Effect of growth hormone replacement on BMD in adult-onset growth hormone deficiency","volume":"22","author":"Snyder","year":"2007","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113362496500_B41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ghir.2005.03.005","article-title":"Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome","volume":"15","author":"Tanriverdi","year":"2005","journal-title":"Growth Horm IGF Res"},{"key":"key\n\t\t\t\t2019041113362496500_B42","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1590\/S0004-27302008000500021","article-title":"Efficacy, safety and compliance of long-term growth hormone (GH) replacement therapy in adults with GH deficiency","volume":"52","author":"Zaninelli","year":"2008","journal-title":"Arq Bras Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113362496500_B43","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.medcli.2010.07.030","article-title":"Long term treatment with growth hormone deficiency in adults","volume":"136","author":"Cabo","year":"2011","journal-title":"Med Clin (Barc)"},{"key":"key\n\t\t\t\t2019041113362496500_B44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ghir.2011.01.001","article-title":"Favorable long-term effects of growth hormone replacement therapy on quality of life, bone metabolism, body composition and lipid levels in patients with adult-onset growth hormone deficiency","volume":"21","author":"Jorgensen","year":"2011","journal-title":"Growth Horm IGF Res"},{"key":"key\n\t\t\t\t2019041113362496500_B45","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/MED.0b013e3283319e6d","article-title":"Growth hormone and bone","volume":"16","author":"Tritos","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"key\n\t\t\t\t2019041113362496500_B46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000063443","article-title":"Bone densitometry: assessing the effects of growth hormone treatment in adults","volume":"54","author":"Ortolani","year":"2000","journal-title":"Horm Res"},{"key":"key\n\t\t\t\t2019041113362496500_B47","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113362496500_B48","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1210\/jc.2003-032082","article-title":"Efficacy and tolerability of an individualized dosing regimen for adult growth hormone replacement therapy in comparison with fixed body weight-based dosing","volume":"89","author":"Hoffman","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t2019041113362496500_B49","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1530\/EJE-09-0160","article-title":"Is increase in bone mineral content caused by increase in skeletal muscle mass\/strength in adult patients with growth hormone (GH) treated GH deficiency? A systematic literature analysis","volume":"161","author":"Klefter","year":"2009","journal-title":"Eur J Endocrinol"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/3\/852\/11157950\/jcem0852.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T09:24:40Z","timestamp":1565083480000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/99\/3\/852\/2537053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,1]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2013-3921","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718238703.793538654","asserted-by":"object"}]},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,1]]}}}